Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-11-30Clinical Trial Update: Evaluate the Meritup Oral Solution to Decrease Fatigue in Metastatic Breast Cancer Patients Receiving Chemotherapy [Phase 2]
Phase 2 clinical trial evaluating Meritup oral solution to decrease fatigue in metastatic breast cancer patients undergoing chemotherapy.
-
CLINICAL_TRIALS trial_result · 2023-11-27Clinical Trial Update: Fulvestrant With or Without Bortezomib in Patients With Inoperable Locally Advanced or Metastatic Estrogen Receptor Positive Breast Cancer [Phase 2]
A Phase 2 trial evaluating fulvestrant with or without bortezomib in patients with operable locally advanced or metastatic estrogen receptor…
-
CLINICAL_TRIALS trial_result · 2023-11-24Clinical Trial Update: Investigating the Biological Effects of the Addition of Zoledronic Acid to Pre-operative Chemotherapy in Breast Cancer [Phase 2]
Phase 2 trial evaluating the biological effects of adding zoledronic acid to pre-operative chemotherapy in breast cancer has been completed.
-
CLINICAL_TRIALS trial_result · 2023-11-22Clinical Trial Update: Fasting Mimicking Diet Program to ImpRovE ChemoTherapy in Hormone Receptor Postive (HR+), HER2- Breast Cancer [Phase 3]
A Phase 3 trial evaluating a fasting mimicking diet program to improve chemotherapy outcomes in hormone receptor-positive, HER2-negative bre…
-
CLINICAL_TRIALS trial_result · 2023-11-22Clinical Trial Update: A Window of Opportunity Study of Pre-operative Endocrine Therapy With and Without Prometrium in Postmenopausal Women With Early Stage Breast Hormone Receptor Positive (HR+) Human Epidermal Receptor 2 Negative (HER2-) Breast Cancer. [Phase 2]
Phase 2 clinical trial update examining pre-operative endocrine therapy with and without Prometrium (progesterone) in postmenopausal women w…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-11-21Clinical Trial Update: A Study of Abemaciclib in Indian Women With Advanced Breast Cancer [Phase 4]
Phase 4 trial update of abemaciclib in Indian women with advanced breast cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-11-21Clinical Trial Update: A Study of SHR6390 in Combination With Letrozole or Anastrozole or Fulvestrant in Patients With HR Positive and HER2 Negative Advanced Breast Cancer [Phase 1, Phase 2]
Clinical trial update for SHR6390 in combination with letrozole, anastrozole, or fulvestrant in HR-positive, HER2-negative advanced breast c…
-
CLINICAL_TRIALS trial_result · 2023-11-18Clinical Trial Update: Incidence and Severity of Diarrhea in Patients With HER2 Positive Breast Cancer Treated With Trastuzumab and Neratinib [Phase 2]
Phase 2 trial evaluating the incidence and severity of diarrhea in patients with HER2-positive breast cancer treated with trastuzumab and ne…
-
CLINICAL_TRIALS trial_result · 2023-11-18Clinical Trial Update: A Phase II Study to Explore the Safety, Tolerability, and Preliminary Antitumor Activity of Sitravatinib Plus Tislelizumab or Combination With Nab-paclitaxel in Patients With Locally Recurrent or Metastatic Triple Negative Breast Cancer (TNBC) [Phase 2]
A Phase 2 clinical trial assessing safety, tolerability, and preliminary antitumor activity of Sitravatinib plus Tislelizumab or with Nab-pa…
-
CLINICAL_TRIALS trial_result · 2023-11-15Clinical Trial Update: Dalpiciclib Combination With Fulvestrant and Compound Gossyfol Acetate Tablets in Women With CDK4/6 Inhibitor-refractory HR-positive HER-2 Negtive Metastatic Breast Cancer: a Phase 2 Clinical Trial. [Phase 2]
A Phase 2 trial evaluating dalpiciclib in combination with fulvestrant and compound gossyfol acetate tablets for women with HR-positive, HER…
-
CLINICAL_TRIALS trial_result · 2023-11-14Clinical Trial Update: Study Comparing 4 Cycles With 6 Cycles of TC (Docetaxel+Cyclophosphamide) Adjuvant Chemotherapy for 1-3 Lymph Node Positive ER+/HER2- Early Breast Cancer [Phase 3]
Phase 3 trial comparing 4 cycles versus 6 cycles of TC (docetaxel + cyclophosphamide) as adjuvant chemotherapy for early breast cancer with …
-
FDA approval · 2023-11-09FDA Approved: ORSERDU — Supplemental Application (Stemline Therapeutics, Inc.)
The FDA approves a supplemental application for ORSERDU (elacestrant) submitted by Stemline Therapeutics, Inc.
-
CLINICAL_TRIALS trial_result · 2023-11-09Clinical Trial Update: Neoadjuvant Pembrolizumab + Decitabine Followed by Std Neoadj Chemo for Locally Advanced HER2- Breast Ca [Phase 2]
Phase 2 trial evaluating neoadjuvant pembrolizumab plus decitabine followed by standard neoadjuvant chemotherapy for locally advanced HER2-n…
-
CLINICAL_TRIALS trial_result · 2023-11-09Clinical Trial Update: Pilot Study of Oxytocin and microRNA Identification in NAF, Serum, and Tissue in Women With Breast Cancer [Phase 2]
Phase 2 pilot trial investigating oxytocin and microRNA identification in nipple aspirate fluid, serum, and tissue from women with breast ca…
-
CLINICAL_TRIALS trial_result · 2023-11-08Clinical Trial Update: Utidelone in Combination With AC Versus Docetaxel in Combination With AC for Neoadjuvant Chemotherapy in Patients With HER2-negative Breast Cancer [Phase 3]
Phase 3 trial comparing Utidelone with AC versus Docetaxel with AC as neoadjuvant therapy for HER2-negative breast cancer is ongoing or not …
-
CLINICAL_TRIALS trial_result · 2023-11-07Clinical Trial Update: Reducing Pain and Disability After Breast Cancer Surgery [NA]
This clinical trial update reports a completed study aimed at reducing pain and disability after breast cancer surgery, with results posted …
-
CLINICAL_TRIALS trial_result · 2023-11-07Clinical Trial Update: Neoadjuvant TCHP Versus THP in Patients With HER2-positive Breast Cancer (neoCARHP Study) [Phase 3]
Phase 3 trial comparing neoadjuvant TCHP versus THP in HER2-positive breast cancer (neoCARHP); status not specified.
-
CLINICAL_TRIALS trial_result · 2023-11-07Clinical Trial Update: PIPAC Nab-pac for Stomach, Pancreas, Breast and Ovarian Cancer [Phase 1]
Phase 1 trial update of PIPAC nab-paclitaxel for peritoneal carcinomatosis in stomach, pancreas, breast, and ovarian cancers with completed …
-
CLINICAL_TRIALS trial_result · 2023-11-01Clinical Trial Update: Pivotal Study in HER2 Negative, Locally Recurrent or Metastatic Breast Cancer [Phase 3]
A Phase 3 pivotal study in HER2-negative locally recurrent or metastatic breast cancer was terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2023-11-01Clinical Trial Update: Tamoxifen Prediction Study in Patients With ER+ Breast Cancer [Phase 4]
Phase 4 clinical trial update on tamoxifen prediction in ER-positive breast cancer patients.
-
CLINICAL_TRIALS trial_result · 2023-10-30Clinical Trial Update: Phase III Clinical Trial Comparing the Safety, Efficacy, and Immunogenicity of HS022 and Trastuzumab® in Combination With Vinorelbine Bitartrate Injection in the Treatment of HER2-positive Breast Cancer [Phase 3]
Phase III trial comparing HS022 to trastuzumab in combination with vinorelbine for HER2-positive breast cancer completed.
-
CLINICAL_TRIALS trial_result · 2023-10-30Clinical Trial Update: A Study Evaluating the Safety, Pharmacokinetics and Efficacy of Ipatasertib Administered in Combination With Rucaparib in Participants With Advanced Breast, Ovarian Cancer, and Prostate Cancer. [Phase 1]
Phase 1 trial evaluating safety, pharmacokinetics, and efficacy of Ipatasertib with Rucaparib in advanced breast, ovarian, and prostate canc…
-
CLINICAL_TRIALS trial_result · 2023-10-27Clinical Trial Update: Tucatinib, Palbociclib and Letrozole in Metastatic Hormone Receptor Positive and HER2-positive Breast Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating tucatinib, palbociclib, and letrozole in metastatic hormone receptor-positive and HER2-positive breast c…
-
CLINICAL_TRIALS trial_result · 2023-10-27Clinical Trial Update: Use of GnRHa During Chemotherapy for Fertility Protection [Phase 3]
Phase 3 trial investigating GnRHa during chemotherapy to protect fertility in cancer patients; currently recruiting.
-
CLINICAL_TRIALS trial_result · 2023-10-26Clinical Trial Update: Correlate BRCA1 Protein Expression With Response to DNA Damaging Chemotherapy [Phase 2]
Phase 2 trial updating correlation of BRCA1 protein expression with response to DNA-damaging chemotherapy in breast cancer.